Antibody-Guided Therapy in Phospholipase A2 Receptor-Associated Membranous Nephropathy

INTRODUCTION: A 6-month course of cyclophosphamide (CP) and steroids is effective in primary membranous nephropathy (MN), but unappealing because of long-term side effects. We evaluated efficacy of an “antibody-guided” treatment schedule. METHODS: Patients with phospholipase A2 receptor (PLA2R)-rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Vink, Coralien H., Logt, Anne-Els van de, van der Molen, Renate G., Hofstra, Julia M., Wetzels, Jack F.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014436/
https://www.ncbi.nlm.nih.gov/pubmed/36938074
http://dx.doi.org/10.1016/j.ekir.2022.12.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014436/
https://www.ncbi.nlm.nih.gov/pubmed/36938074
http://dx.doi.org/10.1016/j.ekir.2022.12.003

Ejemplares similares